Login / Signup
Historical Perspective of High-Dose Therapy Followed by Autologous Stem Cell Transplantation in Multiple Myeloma.
Inbar Cohen
Iuliana Vaxman
Morie A Gertz
Published in:
Acta haematologica (2024)
HDT followed by ASCT remains part of SOC due to its PFS benefit and relatively low toxicity.
Keyphrases
</>
stem cell transplantation
high dose
multiple myeloma
low dose
cell therapy
bone marrow
oxidative stress
platelet rich plasma
stem cells